Antibody & Monoclonal Therapeutics

Therapeutic antibodies and monoclonal antibody technologies play a pivotal role in preventing and treating a wide range of diseases, including cancer, infectious diseases, and autoimmune disorders. Research focuses on antibody design, engineering, and optimization to enhance specificity, efficacy, and safety. Novel approaches include bispecific antibodies, antibody-drug conjugates, and humanized monoclonal antibodies. These therapies can neutralize pathogens, modulate immune responses, or target disease-specific cells. Advances in antibody therapeutics continue to expand personalized medicine, offering precise, effective, and adaptable treatment options for diverse clinical challenges.

    Related Conference of Antibody & Monoclonal Therapeutics

    March 12-13, 2026

    8th International Conference on Digital Health

    London, UK
    April 08-09, 2026

    5th International Congress on Global Healthcare

    Vienna, Austria
    April 20-21, 2026

    7th Global Summit on Digital Therapeutics

    Barcelona, Spain
    April 27-28, 2026

    8th World Summit on Women's Health and Cancer Awareness

    Vancouver, Canada
    June 01-02, 2026

    2nd International Congress on Primary Health and Safety

    Zurich, Switzerland
    June 15-16, 2026

    8th World Conference on Vaccine and Immunology

    Paris, France
    July 13-14, 2026

    13th World congress on Hospice and Palliative care

    Amsterdam, Netherlands
    July 23-24, 2026

    37th European Heart and Heart Failure Congress

    Paris, France
    August 27-28, 2026

    22nd Global Biomarkers and Clinical Research Summit

    Paris, France
    October 19-20, 2026

    6th Euro-Global Summit on Probiotics & Nutraceuticals

    Paris, France
    December 16-17, 2026

    7th Global Summit on Public Health

    Amsterdam, Netherlands

    Antibody & Monoclonal Therapeutics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in